Flash Player 6+ Required for Site Navigation.

919-883-9113
 
Flash Player 6+ Required.
 
 
 
 

 

 
 
 
 

NEWS 2

 

Device Gets Long-Awaited OK.

Former cancer patient's company may take off with an invention born of necessity.

 

by Anne Krisnan

Staff Writer

News & Observer, Raleigh

 

 

 

 

 

NEWS


FOR IMMEDIATE RELEASE:

For Patients, Inc.'s CathSlingCathSling Trademark Has Been Approved for Medicare Reimbursement

Chapel Hill, North Carolina
June 19, 2006


  For Patients, Inc., a North Carolina Corporation established to provide innovative medical products for patients receiving treatment for chronic illnesses, has received approval for Medicare Reimbursement for its central venous catheter support, the CathSlingCathSling Trademark.

The CathSling, a patent-pending, FDA regulated, non-adhesive medical device was invented by For Patients Inc.'s founder, Carol Walborn, while she was a cancer patient undergoing chemotherapy treatment at UNC Healthcare.

The CathSling is a simple, disposable fabric necklace that supports the external access tubing of certain central venous catheters, access needles for the portacath CVC during infusions and the IV lines attached to a Peripherally Inserted Central Catheter (PICC).

The patient, chronically ill for months or years, is implanted with a central venous catheter (CVC) to allow ongoing chemotherapy and blood transfusions without the need for multiple daily needle sticks. The CathSling allows the patient to support their IV lines and the catheter lumens (external tubes to which IV lines are attached) while asleep, while walking or sitting, while in the shower and during any other activity as permitted by their physician.

"Most of the patients that can benefit from using the CathSling are being treated for a variety of critical diseases which include undergoing chemotherapy, bone marrow transplants, hemodialysis, intra-cardiac pressure monitoring and perenteral nutrition," said Carol Walborn, Founder and CEO of For Patients Inc.

"The CathSling not only improves patient quality of life, it may reduce additional healthcare costs related to infection and dislodgement. Medicare reimbursement allows more hospitals, clinics, hospices and home health agencies the ability to supply patients with this unique device affordably", she points out.

The CathSling has completed a field trial at Duke Medical Center and received full recommendation for purchasing based upon the positive feedback from nurses and patients.
 

 

 
 
 

  For Patients, Inc.

 

Home   |   Patients   |   Providers   |   Distributors   |   About Us   |   News   |   Contact   |   Site Map